Search

everythinglearnresearchcommunity

for

Search:↓

A testosterone-induced hair loss model in mice was successfully created for future research and treatment testing.

Post-finasteride syndrome can cause sexual and systemic side effects, and patients should be informed about these risks.

Five new mutations in the androgen receptor gene were found, helping to understand androgen insensitivity syndrome better.

Early diagnosis and treatment of NCCAH can improve symptoms and fertility.

A 15-year-old girl with no menstrual period was diagnosed with a genetic condition that makes her body unable to respond to male hormones, leading to female characteristics despite having male genetic makeup.

Finasteride treatment may cause erectile dysfunction, but stopping it reverses these effects.

Steroid cell tumors in ovaries are rare, can cause hormone changes, and may be cancerous.

Finasteride reduces Tourette syndrome symptoms, but results may be limited due to potential biases.

A rare ovarian tumor can cause unusual male-like symptoms, but surgery usually leads to a good outcome.

A woman with a rare adrenal tumor and hormonal disorder had improved testosterone levels after surgery, but her menstrual irregularities continued.

Both finasteride and drospirenone treatments improved symptoms and increased pregnancy rates in women with polycystic ovary syndrome.

Finasteride for hair loss in young men may significantly increase the risk of sexual dysfunction.

Finasteride affects male rat genitalia development, causing abnormalities during specific pregnancy days.

A man with a weakened immune system was diagnosed with a rare skin condition called trichodysplasia spinulosa using skin examination techniques.

A rare ovarian cancer with a good outlook was found in a woman with unusual hair growth and abdominal symptoms.

Women with nonclassical congenital adrenal hyperplasia may have a higher risk of fertility issues and miscarriages, and should get genetic counseling.

Androgenetic alopecia is more common in men, often linked to genetics and hormones.

The combined therapy improved symptoms in PCOS patients.

Estradiol and castration reduced prostate cancer development in rats when applied at early stages, but were ineffective after cancer was established.

Higher testosterone and DHT levels are not linked to urinary symptoms in men.

Men with BPH should discuss potential sexual side effects with doctors before treatment, as some treatments can affect ejaculation.

Male hormones and reduced plakoglobin can impair heart electrical function and increase arrhythmia risk in males.

Man experienced post-finasteride syndrome symptoms after using finasteride and dutasteride for hair loss.

The skin condition Ulerythema ophryogenes did not improve with treatment in a patient with other birth defects.

Finasteride appears safe for long-term sperm concentration, but more research is needed for clear conclusions.

Baldness may lower the risk of testicular cancer.